ResearcherSHOWA Medical UniversityActive in the last 2 years

Shu Oikawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7242-1734; OpenAlex author ID A5046365814. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Comparative Prognostic Roles of β-Catenin Expression and Tumor-Stroma Ratio in Pancreatic Cancer: Neoadjuvant Chemotherapy vs. Upfront Surgery. Co-author DOI 10.3390/curroncol32100578 ↗
Association Between ABCC2 -24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic Cancer. Co-author DOI 10.21873/anticanres.17326 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hitoshi Yoshida · 2 shared papers, 2024–2025 · strength 0.42
- Paper Comparative Prognostic Roles of β-Catenin Expression and Tumor-Stroma Ratio in Pancreatic Cancer: Neoadjuvant Chemother… DOI 10.3390/curroncol32100578 ↗
- Paper Association Between ABCC2 -24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic … DOI 10.21873/anticanres.17326 ↗
Ken-Ichi Fujita · 1 shared paper, 2024 · strength 0.16
- Paper Association Between ABCC2 -24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic … DOI 10.21873/anticanres.17326 ↗
Hana Nakayama · 1 shared paper, 2024 · strength 0.16
- Paper Association Between ABCC2 -24C>T and Nab-Paclitaxel-induced Peripheral Neuropathy in Japanese Patients With Pancreatic … DOI 10.21873/anticanres.17326 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.